Stent sizing in imaging-guided percutaneous coronary intervention: potential benefits of a more cautious approach

2024-9-1

Severe aortic regurgitation: the limits of TAVI

2024-9-1

Clinical outcomes of acute limb ischaemia caused by femoropopliteal stent thrombosis

2024-9-1

Treatment extent of femoropopliteal disease and clinical outcomes following endovascular therapy

2024-9-1

Acute limb ischaemia from stent thrombosis: bad luck or bad protoplasm?

2024-9-1

IVUS has more robust data than OCT for PCI guidance: PROS and CONS

2024-9-1

Characterisation and distribution of human coronary artery innervation

2024-9-1

Optical frequency domain imaging-guided versus intravascular ultrasound-guided percutaneous coronary intervention for acute coronary syndromes: the OPINION ACS randomised trial

2024-9-1

A new resorbable magnesium scaffold (DREAMS 3G): 12-month vasomotion results from the BIOMAG-I first-in-human study

2024-9-1

Temporal trends and outcomes of acute ischaemic strokes in patients hospitalised for percutaneous coronary intervention

2024-9-1

Percutaneous transvalvular microaxial flow pump is underused in infarct-related cardiogenic shock: pros and cons

2024-9-1

Drug-eluting devices for lower limb peripheral arterial disease

2024-9-1

Serial intracoronary imaging to predict efficacy and safety of magnesium-based resorbable scaffolds

2024-9-1

Impact of lesion morphology on stent elongation during bifurcation PCI: an in vivo OCT study

2024-9-1

Navigating the heart – insights into human coronary artery innervation

2024-9-1

Vascular response following implantation of the third-generation drug-eluting resorbable coronary magnesium scaffold: an intravascular imaging analysis of the BIOMAG-I first-in-human study

2024-9-1

Expanding our understanding on stent expansion

2024-9-1

Is it time for a myocardial infarction approach to high- and intermediate-high-risk pulmonary embolism?

2024-9-1

Outcomes of transcatheter aortic valve implantation for native aortic valve regurgitation

2024-9-1

Aortic regurgitation: from mechanisms to management

2024-9-1

Outcomes of newly diagnosed atrial fibrillation in patients with acute coronary syndromes

2024-8-1

Recyclable and contaminated waste from cardiac procedures: a call to action for a sustainable catheterisation laboratory and operating theatre

2024-8-1

Double-tap to treat paravalvular leak in high-risk annuli

2024-8-1

Reply: Identifying vulnerable coronary atherosclerotic plaques: from theory to practice

2024-8-1

Letter: Biological differences of three paclitaxel- and sirolimus-coated balloons on coronary lesions in a rabbit model

2024-8-1

   Atrial fibrillation and acute coronary syndrome 

2024-8-1

Impella – a treatment for all STEMI patients with cardiogenic shock? The effect of off-hours admission

2024-8-1

Beyond residual stenosis: morphofunctional assessment following primary PCI in acute coronary syndrome

2024-8-1

A comparison of simplified or conventional antithrombotic regimens after left atrial appendage closure in patients at high bleeding risk: the PLATEBRISK study

2024-8-1

Impact of off-hours admissions in STEMI-related cardiogenic shock managed with microaxial flow pump – insights from J-PVAD

2024-8-1

Determinants of adverse outcomes following patent foramen ovale closure in elderly patients

2024-8-1

Concomitant left atrial appendage occlusion in patients undergoing mitral transcatheter edge-to-edge repair: pros and cons

2024-8-1

Percutaneous coronary intervention for bifurcation coronary lesions using optimised angiographic guidance: the 18th consensus document from the European Bifurcation Club

2024-8-1

Five-year follow-up of OCT-guided percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction

2024-8-1

Changes in absolute coronary flow and microvascular resistance during exercise in patients with ANOCA

2024-8-1

Antithrombotic therapy for transcatheter structural heart intervention

2024-8-1

Left atrial appendage occlusion needs lifetime management not lifetime medications

2024-8-1

Work in progress: OCT-guided coronary interventions in the acute setting

2024-8-1

The patent foramen ovale does not spontaneously close in patients aged 60

2024-8-1

Diagnostic accuracy of quantitative flow ratio in patients with arrhythmias

2024-8-1

Letter: Identifying vulnerable coronary atherosclerotic plaques: from theory to practice

2024-8-1

A-Flux: a novel self-expanding coronary sinus reducer for refractory angina

2024-8-1

Impact of morphofunctional assessment with quantitative flow ratio and optical coherence tomography in patients with acute coronary syndromes

2024-8-1

Is bivalirudin ready for a comeback? Pros and cons

2024-8-1

Reply: Biological differences of three paclitaxel- and sirolimus-coated balloons on coronary lesions in a rabbit model

2024-8-1

Five-year outcomes of transcatheter aortic valve implantation with the ACURATE neo2 valve system

2024-7-29

Angioplasty with drug-coated balloon catheters: the coming tide?

2024-7-1

Subclinical leaflet thrombosis: should we be concerned?

2024-7-1

Clinical outcomes and predictors of transapical transcatheter mitral valve replacement: the Tendyne Expanded Clinical Study

2024-7-1

Temporary omission of oral anticoagulation in atrial fibrillation patients undergoing percutaneous coronary intervention: rationale and design of the WOEST-3 randomised trial

2024-7-1